(1) Patients with early-stage breast cancer should be followed up regularly after surgery to understand their survival status, as well as their compliance with adjuvant therapy and adverse reactions. (2) Follow-up time: every 3 months in the 1st~2nd year after surgery (or after finishing adjuvant chemotherapy), every 4~6 months in the 3rd~4th year, and 1~2 times a year from the 5th year. Personally, I suggest that patients with triple negative breast cancer should increase the frequency of follow-up examinations appropriately. (3) Follow-up examinations: physical examination by palpation, liver ultrasound, blood biochemistry and blood routine, tumor serological index. (4) Other special examinations: mammography (once a year), gynecological examination (once a year in triamcinolone or toremifene treatment), bone density (in aromatase inhibitor treatment). (5) Bone scans, CT or MRI may be used in symptomatic patients, but are not recommended routinely in asymptomatic patients.